Removing Barriers To Healthcare With Our Pocket-Friendly Qualinomic Antibiotic Range

The only thing worse than falling sick is feeling like you cannot afford to. 

According to a WHO report, 67.78% of total expenditure on health in India is paid out of pocket, while the world average is just 18.2% (2017). For a lot of Indian households, the amount spent on medicines can put a huge dent in savings.

In fact, most people stop taking antibiotics midway when they feel better because of economic reasons. Discontinuing medication — especially antibiotics because of a “lack of affordability” can be detrimental to health in the long run.

Most common reasons why people discontinue antibiotic courses:

  1. They may lack awareness about the significance of  “duration” in treatment
  2. They assume that an improvement in symptoms = freedom from infection
  3. They cannot afford to complete the full course due to the high cost of antibiotics 

When it comes to treating infections, “length of the course” plays a crucial role in determining the success of the medication. The doses and duration of antibiotics prescribed by a doctor are not decided at random but are based on extensive research and clinical evidence. Stopping a course of antibiotics when symptoms improve can lead to antibiotic resistance.

What is antibiotic resistance?
When an antibiotic course is discontinued before the infection is completely treated, the bacteria and fungi become immune/ resistant to the medications meant to kill them. The infections caused by these new antibiotic-resistant germs are not only challenging to treat but can also burn a hole in your pocket by requiring extended hospital stays, doctor visits and expensive higher antibiotics. When antibiotics lose effectiveness, they become useless to treat infections — ultimately burdening the healthcare system with new and powerful bacterial variants.

There is a need to educate people about their diagnosis, treatment and the consequences of discontinuing antibiotics at their own discretion.

At Ozone Group of Companies, we believe that life is precious and quality healthcare shouldn’t cost people an arm and a leg. As an organization committed to improving people’s quality of life, we want to eliminate “affordability” as a barrier that prevents people from receiving the care they rightfully deserve.

That’s why we launched our Pocket-Friendly Qualinomic Antibiotic Range.

Providing high-quality medication at the most economical price, the “Qualinomic Range” of antibiotics attempts to improve access to affordable antibiotics, while ensuring uncompromised quality for favourable results.

Adding life to years and years to life has always been at the forefront of our therapies, research and innovation. To stay committed to the quality of medications, Ozone Group of Companies has its own state-of-the-art Analytical Lab equipped with modern machinery and mechanisms that enable a quality analysis of pharmaceutical products. Furthermore, Ozone Brands are tested, beyond chemical equivalence, for the desired bio-equivalence, ensuring the highest percentage of active ingredients in the formulations.

Our Pocket-Friendly Qualinomic Antibiotic Range includes:

  1. CEFILAB Range:
    • To treat Lower Respiratory Tract Infections
      Cefilab®-200/100 Tablet (Cefixime 200/100mg)  
    • To treat Urinary Tract Infections and Lower Respiratory Tract Infections
      Cefilab®-CV Tablet (Cefixime 200mg + Clavulanic Acid 125mg )
    • To treat Typhoid
      Cefilab®-O Tablet (Cefixime 200mg + Ofloxacin 200mg)  
  1. OZOROX Range:
    • For effective management of Upper Respiratory Tract.
      Ozorox®- 250/500 Tablet (Azithromycin 250/500 mg)
  1. C4U (Care 4 You):
    • For Upper Respiratory Tract Infections and Acute Otitis Media.
      C4U® Tablet (Cefpodoxime 200mg+ Clavulanic Acid 125mg)  
  1. UNEEK Range:
    • For Urinary Tract Infections,
      UNEEK® Tablet (Ofloxacin 200 mg, LAB 60 million spores) 
      UNEEK® Suspension (Each 5ml contains Ofloxacin 50mg)  
    • For Diarrhea & Dysentery
      UNEEK®- OZ Tablet (Ofloxacin 200 mg + Ornidazole 500mg)  
  1. XPAND Range: 
    • For Pharyngitis and Community-Acquired Pneumonia
      XPAND®- 625 Tablet (Amoxycillin 500mg+ Clavulanic Acid 125mg) 

We understand that non – adherence to the complete course of antibiotic prescriptions can have far-reaching consequences for the patient and public health at large. We are proud to launch our Pocket-Friendly Qualinomic Antibiotic Range and do our part in improving adherence and ensuring patients make a full recovery. The Pocket-Friendly Qualinomic Antibiotic Range helps further our vision of making a ‘better’ life affordable, accessible and attainable for all.

Learn more about our other life-changing therapies here:

Subscribe to new posts

Leave a Reply

Your email address will not be published. Required fields are marked *